Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New nurse training boosts palliative care skills in oman

NCT ID NCT07460570

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a special training program for oncology nurses in Oman to help them care for patients with serious cancer and those nearing the end of life. 189 nurses took part, with some receiving the training and others continuing their usual work. The program aimed to improve nurses' knowledge, attitudes, and communication skills for palliative care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

189 people

The number who actually took part.

Started

Apr 2025

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Registered nurses working in participating oncology/cancer care settings in Oman * Providing direct clinical care to patients with cancer * Employed at the study site during the study period and expected to remain for the duration of the intervention and follow-up assessments * Aged 18 years or older * Able to read and understand the study materials and questionnaires * Willing to participate and provide informed consent Exclusion Criteria: * Nursing students, interns, or non-registered nursing staff * Nurses not providing direct patient care (e.g., administrative/managerial roles without bedside clinical duties) * Nurses on extended leave during the intervention or follow-up period (e.g., annual leave, sick leave, maternity leave) * Nurses who did not complete the baseline (pre-intervention) assessment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Neoplasms (cancer / tumors) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Royal Hospital

    Muscat, PC123, Oman

  • Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), University Medical City

    Muscat, PC123, Oman

More trials for these conditions

Other studies related to the condition(s) this trial covers.